Bioprocess Bags Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 4.28 Billion |
| Market Size (2029) | USD 9.68 Billion |
| CAGR (2024 - 2029) | 17.75 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Bioprocess Bags Market Analysis
The Bioprocess Bags Market size is estimated at USD 4.28 billion in 2024, and is expected to reach USD 9.68 billion by 2029, growing at a CAGR of 17.75% during the forecast period (2024-2029).
The primary drivers of the market are the increasing demand for pharmaceutical drugs, several advantages associated with implementing single-use systems (SUS), widespread adoption of SUS technology among CMOS, and product launches.
The increasing demand for pharmaceutical drugs is one of the critical drivers for the market. For instance, an article published by the Coalition For A Prosperous America Organization in March 2024 mentioned that pharmaceutical imports increased in 2023, accounting for USD 208 billion, solidifying their position as the second-largest import category for US consumer goods. Regarding weight, China and India contributed 57.6% to the total pharmaceutical imports in 2023. Bioprocess bags are used to transfer and store products throughout the drug manufacturing process. They help keep various liquids during the drug development without the risk of contamination. Thus, increasing demand for pharmaceutical drugs globally is expected to positively impact market growth over the forecast period.
Furthermore, the rising adoption of single-use technologies across the globe is also expected to propel market growth. For instance, according to the journal published by the Annual Review of Chemical and Biomolecular Engineering in June 2022, single-use technologies transformed conventional biopharmaceutical manufacturing, and their adoption is proliferating for emerging applications such as antibody-drug conjugates and cell and gene therapy products. The critical factor for the rising adoption of single-use technologies is their several advantages. They offer increased productivity, simplified disposal, and minimal chance of cross-contamination. Owing to these advantages, biopharmaceutical companies and contract manufacturers are now widely adopting single-use technologies. The cost and complexity of automation are significantly reduced, and complex steps such as cleaning and verification between production stages can be omitted with single-use technologies. Therefore, due to such advantages, the adoption of single-use technologies is expected to increase in various sectors, lead to an increase in the adoption of bioprocess bags, and contribute to market growth.
Moreover, market players employ various strategies, such as product launches, which are anticipated to drive market growth. For instance, in March 2022, ILC Dover LP launched its liquid disposable bioprocess bags, the first of many new products for handling and delivering sterile liquids for the biotherapeutics market. Additionally, in February 2022, Dow, Sartorius, and SUDPACK MEDICA collaborated to aid the global coronavirus vaccination drive by producing bioprocessing bags, which are the crucial components for the secure production and distribution of coronavirus vaccines worldwide. Thus, such product launches and collaborations are expected to contribute to market growth.
Therefore, owing to the abovementioned factors, such as the rising demand for pharmaceutical drugs, increasing adoption of single-use technologies, and product launches, are expected to boost market growth. However, the high cost of single-use equipment and limited adoption in downstream processing may restrain market growth over the forecast period.
Bioprocess Bags Market Trends
Single-use Bioprocess Bags Segment is Expected to Witness Considerable Growth Over the Forecast Period
Single-use bioprocess bags provide a streamlined way to enhance manufacturing productivity. It offers strength, durability, and temperature resistance, and a single-use bioprocess bag is durable enough to withstand human and machine handling via specialized pharmaceutical equipment. Single-use bioprocess bags are commonly used to safely handle biopharmaceutical liquids in the process environment. They can be used from small research to mass production. Single-use bioprocess bags come in various sizes and are designed to contain reactions consisting of sterile media, cell cultures, sera, buffers, and reagents.
The increasing production of pharmaceutical drugs is due to biopharmaceutical companies' rising research and development expenditure. For instance, according to the report published by the European Federation of Pharmaceutical Industries and Associations in 2024, the pharmaceutical industry invested the most in research and development (R&D) relative to its sales. Additionally, the report stated that the health industries' R&D investment reached EUR 261.4 billion in 2022, representing 20.9% of global business R&D expenditure. Hence, with strong investments in research and development activities and a pipeline of therapeutics under development, the demand for single-use bioprocess bags is expected to increase as it is one of the significant requirements for drug development and research.
Furthermore, market player initiatives, such as collaborations, are also expected to fuel segment growth over the forecast period. For instance, in April 2023, Repligen Corporation completed the acquisition of FlexBiosys Inc. This acquisition expands Repligen's Fluid Management portfolio by incorporating a comprehensive selection of single-use bioprocessing bags and assemblies into its existing product portfolio. Thus, such collaborations between market players may lead to the greater availability of single-use bioprocess bags in the coming years.
Therefore, owing to the initiatives by market players and increasing investment in research and development in biopharmaceutical companies, which leads to rising drug development, considerable segment growth is anticipated over the forecast period.
North America is Expected to Hold a Significant Share Over the Forecast Period
The North American market for bioprocess bags is expected to grow due to primary factors such as the presence of well-established biopharmaceutical companies and an increase in the number of biotech companies.
The increased research and development expenditure in the region is also expected to drive market growth. For instance, in the data provided by the Organization for Economic Co-operation and Development in November 2022, the research and development expenditure by the biotechnology industries in Canada was USD 651.0 million. Furthermore, increasing government initiatives such as high investments in developing various biotechnology research are expected to boost the North American market. For instance, the article published by the government of Canada in August 2022 mentioned that it invested more than USD 2.2 billion over seven years to boost biomanufacturing. The increasing investment in biopharmaceutical research and development in the region is expected to accelerate the rate of drug development. Bioprocess bags are one of the essential requirements for the storage and transportation of drugs during the development process. Thus, the increasing rate of drug development in the region is expected to impact market growth positively.
The rising investments in research and development and strategic initiatives by the key players are the major drivers for the market in the United States. For instance, in June 2022, Thermo Fisher Scientific opened a single-use technology (SUT) manufacturing site in Utah. Thermo Fisher has developed a 55,000-sq. ft facility in Ogden to manufacture bioprocess container systems, such as single-use bioprocess bags, that can be customized. These systems can be used in many production steps, such as processing, separation, and storage.
Furthermore, the increasing pharmaceutical research and development expenditure in the United States is also expected to drive the market's growth over the forecast period. For instance, according to a report published by the Pharmaceutical Research and Manufacturers of America (PhRMA), the PhRMA members individually invested approximately USD 100,845.2 million in 2022 in research and development to promote clinical and biological research activities in the United States. Such high research and development expenditures are expected to favor the market growth in North America over the forecast period.
Therefore, the abovementioned factors, such as the increase in research and development expenditures and government and market player initiatives, are expected to boost the usage of bioprocess bags in the biopharmaceutical industry and contribute to market growth in North America.
Bioprocess Bags Industry Overview
The bioprocess bags market is moderately fragmented and competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the major players use various strategies such as expansions, agreements, joint ventures, acquisitions, new product launches, and partnerships to increase their footprints in this market. Some of the companies that are currently dominating the market are Corning Incorporated, Charter Medical, Danaher Corporation (Cytvia), and Avantor Inc.
Bioprocess Bags Market Leaders
-
Corning Incorporated
-
Charter Medical
-
Danaher Corporation (Cytiva)
-
Entegris
-
Avantor Inc.
*Disclaimer: Major Players sorted in no particular order
Bioprocess Bags Market News
- June 2024: Qosina introduced new iDOT single-use sensor bag ports from Polestar Technologies. The iDOT sensor configuration makes it easy to add pH and dissolved oxygen (DO) monitoring to single-use bags, such as bioreactors and streamlines the bioprocessing process.
- April 2024: SaniSure introduced Fill4Sure, a customizable single-use filling assembly that accelerates drug market entry, enhances security, streamlines efficiency, and ensures consistency in drug product filling. Fill4Sure comprises advanced features such as ultra-clean, low-particulate 2D surge bioprocess bags, which help minimize contamination and ensure product purity, thus improving the bioprocessing devices.
Bioprocess Bags Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumption and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand For the Pharmaceutical Drugs
4.2.2 Several Advantages Associated With the Implementation of Single-use Systems (SUS) and Product Launches
4.2.3 Widespread Adoption of Single-use Technology Amongst CMOS
4.3 Market Restraints
4.3.1 High Cost of Single-use Equipment
4.3.2 Limited Adoption in Downstream Processing
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value – USD)
5.1 By Product
5.1.1 Single-use Bioprocess Bags
5.1.2 Multi-use Bioprocess Bags
5.2 By Application
5.2.1 Process Development
5.2.2 Upstream Process
5.2.3 Downstream Process
5.2.4 Media Preparation
5.2.5 Other Applications
5.3 By End User
5.3.1 Pharmaceutical and Biotechnology Companies
5.3.2 CMOs and CROs
5.3.3 Academic and Research Laboratories
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Corning Incorporated
6.1.2 Charter Medical
6.1.3 Danaher Corporation (Cytiva)
6.1.4 Entegris
6.1.5 Avantor Inc.
6.1.6 Sartorius AG
6.1.7 ESI Ultrapure
6.1.8 Saint-Gobain
6.1.9 Dow
6.1.10 ESCO Bioengineering Co. Ltd
6.1.11 Thermo Fisher Scientific Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Bioprocess Bags Industry Segmentation
As per the scope of the report, bioprocessing bags are a flexible and customizable solution used to safely handle liquids in bioprocess environments. Bioprocessing bags are used in small research and mass production. The bioprocess bags market is segmented by product, application, end user, and geography. By product, the market is segmented into single-use bioprocess bags and multi-use bioprocess bags. By application, the market is segmented into process development, upstream process, downstream process, media preparation, and others. By end user, the market is segmented into pharmaceutical and biotechnology companies, CMOs and CROs, and academic and research laboratories. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. For each segment, the market size is provided in terms of value (USD).
| By Product | |
| Single-use Bioprocess Bags | |
| Multi-use Bioprocess Bags |
| By Application | |
| Process Development | |
| Upstream Process | |
| Downstream Process | |
| Media Preparation | |
| Other Applications |
| By End User | |
| Pharmaceutical and Biotechnology Companies | |
| CMOs and CROs | |
| Academic and Research Laboratories |
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Bioprocess Bags Market Research Faqs
How big is the Bioprocess Bags Market?
The Bioprocess Bags Market size is expected to reach USD 4.28 billion in 2024 and grow at a CAGR of 17.75% to reach USD 9.68 billion by 2029.
What is the current Bioprocess Bags Market size?
In 2024, the Bioprocess Bags Market size is expected to reach USD 4.28 billion.
Who are the key players in Bioprocess Bags Market?
Corning Incorporated, Charter Medical, Danaher Corporation (Cytiva), Entegris and Avantor Inc. are the major companies operating in the Bioprocess Bags Market.
Which is the fastest growing region in Bioprocess Bags Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Bioprocess Bags Market?
In 2024, the North America accounts for the largest market share in Bioprocess Bags Market.
What years does this Bioprocess Bags Market cover, and what was the market size in 2023?
In 2023, the Bioprocess Bags Market size was estimated at USD 3.52 billion. The report covers the Bioprocess Bags Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Bioprocess Bags Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Bioprocess Bags Industry Report
Statistics for the 2024 Bioprocess Bags market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Bioprocess Bags analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
